Metraipolis › archive › dc_3218cf70728d

Efficacy and Safety of IDegLira in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials — Europe PMC PMID:40947681

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40947681
DOI
10.2174/0115733998359708250822102217
License (as archived)
solo-consultazione
Archived
2026-11-07T04:43:58.803Z
SHA-256 of the archived text
dcb88d3bdacfcd8d4014ed840fefeace792d82b028bbb1cc67e247d594148605
Stable URL of this page
https://metraipolis.com/documento/dc_3218cf70728d

How to cite

Efficacy and Safety of IDegLira in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials — Europe PMC PMID:40947681 — Europe PMC (en), https://europepmc.org/article/MED/40947681 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3218cf70728d (Metraipolis archive dc_3218cf70728d, sha256 dcb88d3bdacfcd8d4014ed840fefeace792d82b028bbb1cc67e247d594148605)
BibTeX
@misc{dc3218cf70728d,
  title = {Efficacy and Safety of IDegLira in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials — Europe PMC PMID:40947681},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40947681},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3218cf70728d; sha256 dcb88d3bdacfcd8d4014ed840fefeace792d82b028bbb1cc67e247d594148605},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40947681. Agents can read the archived copy with the MCP tool read_document.